- Home
- LSBK vs MNOV Comparison
LSBK vs MNOV Comparison
Compare LSBK & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSBK | MNOV |
|---|---|---|
| Founded | 1891 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.0M | 72.7M |
| IPO Year | 2006 | 2005 |
Fundamental Metrics
Financial Performance| Metric | LSBK | MNOV |
|---|---|---|
| Price | $14.80 | $1.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 9.2K | ★ 80.9K |
| Earning Date | 01-23-2026 | 02-18-2026 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | ★ 105.28 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $27,774,000.00 | $257,917.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.16 | ★ N/A |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $11.50 | $1.13 |
| 52 Week High | $16.95 | $2.20 |
Technical Indicators
Market Signals| Indicator | LSBK | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 35.86 |
| Support Level | $14.53 | $1.25 |
| Resistance Level | $14.98 | $1.34 |
| Average True Range (ATR) | 0.21 | 0.05 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 40.91 | 18.50 |
Price Performance
Historical ComparisonAbout LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.